Janssen Ortho LLC

ACTIVE

RR 2, Manati, Puerto Rico, United StatesSubsidiary

Also known as:

ortho pharmaceutical

manufactura productos

Part of JANSSEN PHARMACEUTICALS, INC.

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

50.0%

Phase 4

50.0%

Trial Status Distribution

Completed

100.0%

Clinical Trials

Trials sponsored by this organization (4)

A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches

Phase 3

Completed

interventional

Dec 2005447 participants

Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine

Phase 4

Completed

interventional

Jun 2005406 participants

A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache

Phase 4

Completed

interventional

Nov 2004378 participants

A Study of 3 Dosage Strengths of Almotriptan Malate (AXERT®) in the Treatment of Acute Migraine in Adolescents

Phase 3

Completed

interventional

Jul 2003866 participants

Approvals

Approvals by Agency

SFDA

Saudi Food and Drug Authority

Approvals

NPRA

National Pharmaceutical Regulatory Agency

Approvals

Recent Approvals

Erleada 60mg Film-Coated Tablets

NPRA

2025-11-28

Prezista 600mg Film Coated Tablet

NPRA

2025-11-28

ERLEADA 60 mg Film-coated Tablet

SFDA

2025-07-18

News

No news articles found

Back to Organizations